Though Jeremy Cohen tried to hide it, I suspect his heart sunk just a little bit when we suggested he give a talk titled ‘Is it really all about the glycocalyx?’ at smaccGOLD.
This talk is the best explanation of the Revised Starling model and the role of the glycocalyx you are ever likely to come across. Furthermore, Jeremy puts these ideas into the context of our specialty’s key randomised control trials — including what we know about fluid resuscitation, ANP, albumin, antithrombin III and steroid administration in the critically ill.
Is this a must listen?
Here is the audio (download the mp3 directly here):
Read Glycocalyx in Critical Illness from the LITFL CCC to learn more about the glycocalyx.